Alamar Biosciences Inc. (ALMR) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $18.85 - $38.54

0.5 Year ALMR Performance Metrics:

Total Return (with DRIP): 54.9% (139.83% CAGR)

Total Return (no DRIP): 54.9% (139.83% CAGR)

Share Price: 54.9% (139.83% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $15,486

Total Return $ (with DRIP): $5,486

ALMR Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

ALMR Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for ALMR

Based on past 0.5-year performance, here are ALMR growth metrics:

Share price CAGR of +139.83%
Dividend CAGR of +0%

Using ALMR CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	ALMR (DRIP)	ALMR - No DRIP
Current Price	$34.07	$34.07
Start Shares	293.51	293.51
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	293.51	293.51
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$34.07	$34.07
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - ALMR

NOTE: Above numbers are our estimate based on ALMR's Dividend and Price CAGR over past 0.5 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Alamar Biosciences Inc. (ALMR) had its IPO on , and is traded on NASDAQ stock exchange.

Alamar Biosciences Inc. is a proteomics company focused on developing tools for protein biomarker detection and analysis. Its core platform, NULISA technology, supports ultra-sensitive liquid biopsy workflows designed to measure disease-related proteins from small biofluid samples. The company offers instruments, consumables, assays, and related services built around its precision proteomics platform, including the ARGO high-throughput system and NULISAseq and NULISAqpcr assay products. Alamar Biosciences serves research and translational science customers across immunology, neurology, oncology, and other areas of disease research. Its products are used by academic institutions, biopharmaceutical companies, contract research organizations, and service laboratories that need high-plex protein analysis for biomarker discovery and diagnostic development. Based in Fremont, California, Alamar Biosciences plays a specialized role in the life sciences tools market by enabling advanced protein detection for early disease research and clinical innovation.

ALMR website: https://alamarbio.com